Literature DB >> 22512972

Blue light cystoscopy for detection and treatment of non-muscle invasive bladder cancer.

J Ryan Mark1, Francisco Gelpi-Hammerschmidt, Edouard J Trabulsi, Leonard G Gomella.   

Abstract

In patients with non-muscle invasive bladder cancer, fluorescence cystoscopy can improve the detection and ablation of bladder tumors. In this paper we describe the technique and practical aspects of hexaminolevulinate (HAL) fluorescence cystoscopy, also known as "blue light cystoscopy".

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22512972

Source DB:  PubMed          Journal:  Can J Urol        ISSN： 1195-9479            Impact factor:   1.344


  9 in total

Review 1.  Emerging endoscopic imaging technologies for bladder cancer detection.

Authors:  Aristeo Lopez; Joseph C Liao
Journal:  Curr Urol Rep       Date:  2014-05       Impact factor: 3.092

Review 2.  Optical Imaging, Photodynamic Therapy and Optically Triggered Combination Treatments.

Authors:  Srivalleesha Mallidi; Bryan Q Spring; Tayyaba Hasan
Journal:  Cancer J       Date:  2015 May-Jun       Impact factor: 3.360

Review 3.  Advances in imaging technologies in the evaluation of high-grade bladder cancer.

Authors:  Dimitar V Zlatev; Emanuela Altobelli; Joseph C Liao
Journal:  Urol Clin North Am       Date:  2015-02-28       Impact factor: 2.241

4.  Comparative Analysis of the Efficacy of Transurethral Bipolar Plasma Needle Electrode and Ring Electrode in the Treatment of Non-Muscle-Invasive Bladder Cancer.

Authors:  Pei Zheng; Jianhua Zhang; Yahong Zhu; Xiaodong Guan; Jianwen Quan; Qi Li; Fen Yi
Journal:  Comput Intell Neurosci       Date:  2022-05-13

Review 5.  Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA.

Authors:  Siamak Daneshmand; Anne K Schuckman; Bernard H Bochner; Michael S Cookson; Tracy M Downs; Leonard G Gomella; H Barton Grossman; Ashish M Kamat; Badrinath R Konety; Cheryl T Lee; Kamal S Pohar; Raj S Pruthi; Matthew J Resnick; Norm D Smith; J Alfred Witjes; Mark P Schoenberg; Gary D Steinberg
Journal:  Nat Rev Urol       Date:  2014-09-23       Impact factor: 14.432

Review 6.  Role of Macroscopic Image Enhancement in Diagnosis of Non-Muscle-Invasive Bladder Cancer: An Analytical Review.

Authors:  Prashant Motiram Mulawkar; Gyanendra Sharma; Ashwin Tamhankar; Utsav Shah; Rickaz Raheem
Journal:  Front Surg       Date:  2022-02-21

Review 7.  Application of nanotechnology in the diagnosis and treatment of bladder cancer.

Authors:  Yadong Xu; Cheng Luo; Jieqiong Wang; Lingwu Chen; Junxing Chen; Tianfeng Chen; Qinsong Zeng
Journal:  J Nanobiotechnology       Date:  2021-11-27       Impact factor: 10.435

8.  Biomarkers to assess the risk of bladder cancer in patients presenting with haematuria are gender-specific.

Authors:  Brian Duggan; Declan O'Rourke; Neil Anderson; Cherith N Reid; Joanne Watt; Hugh O'Kane; Ruth Boyd; David Curry; Mark Evans; Michael Stevenson; Mary Jo Kurth; John V Lamont; Peter Fitzgerald; Mark W Ruddock
Journal:  Front Oncol       Date:  2022-09-23       Impact factor: 5.738

9.  Optimised photodynamic diagnosis for transurethral resection of the bladder (TURB) in German clinical practice: results of the noninterventional study OPTIC III.

Authors:  Thorsten Bach; Patrick J Bastian; Andreas Blana; Angelika Kaminsky; Stefan Keller; Thomas Knoll; Christoph Lang; Soeren Promnitz; Burkhard Ubrig; Thomas Keller; Bryan Qvick; Maximilian Burger
Journal:  World J Urol       Date:  2016-08-30       Impact factor: 4.226
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.